{"pmid":32503848,"title":"Response to: 'Severe COVID-19 associated pneumonia in 3 patients with systemic sclerosis treated with rituximab' by Avouac et al.","text":["Response to: 'Severe COVID-19 associated pneumonia in 3 patients with systemic sclerosis treated with rituximab' by Avouac et al.","Ann Rheum Dis","Guilpain, Philippe","Le Bihan, Clement","Foulongne, Vincent","Taourel, Patrice","Pansu, Nathalie","Maria, Alexandre Thibault Jacques","Jung, Boris","Larcher, Romaric","Klouche, Kada","Le Moing, Vincent","32503848"],"journal":"Ann Rheum Dis","authors":["Guilpain, Philippe","Le Bihan, Clement","Foulongne, Vincent","Taourel, Patrice","Pansu, Nathalie","Maria, Alexandre Thibault Jacques","Jung, Boris","Larcher, Romaric","Klouche, Kada","Le Moing, Vincent"],"date":"2020-06-07T11:00:00Z","year":2020,"_id":"32503848","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1136/annrheumdis-2020-217955","keywords":["b-lymphocytes","autoantibodies","rituximab"],"e_drugs":["Rituximab"],"weight":0,"_version_":1668892488319893504,"score":9.490897,"similar":[{"pmid":32503849,"title":"Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximab.","text":["Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximab.","Ann Rheum Dis","Avouac, Jerome","Airo, Paolo","Carlier, Nicolas","Matucci-Cerinic, Marco","Allanore, Yannick","32503849"],"journal":"Ann Rheum Dis","authors":["Avouac, Jerome","Airo, Paolo","Carlier, Nicolas","Matucci-Cerinic, Marco","Allanore, Yannick"],"date":"2020-06-07T11:00:00Z","year":2020,"_id":"32503849","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1136/annrheumdis-2020-217864","keywords":["inflammation","rituximab","scleroderma","systemic"],"e_drugs":["Rituximab"],"topics":["Case Report"],"weight":1,"_version_":1668892488298921986,"score":107.00134},{"pmid":32312768,"title":"Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia.","text":["Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia.","Ann Rheum Dis","Guilpain, Philippe","Le Bihan, Clement","Foulongne, Vincent","Taourel, Patrice","Pansu, Nathalie","Maria, Alexandre Thibault Jacques","Jung, Boris","Larcher, Romaric","Klouche, Kada","Le Moing, Vincent","32312768"],"journal":"Ann Rheum Dis","authors":["Guilpain, Philippe","Le Bihan, Clement","Foulongne, Vincent","Taourel, Patrice","Pansu, Nathalie","Maria, Alexandre Thibault Jacques","Jung, Boris","Larcher, Romaric","Klouche, Kada","Le Moing, Vincent"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32312768","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1136/annrheumdis-2020-217549","keywords":["communicable diseases, imported","granulomatosis with polyangiitis","hydroxychloroquine","rituximab","systemic vasculitis"],"e_drugs":["Rituximab"],"topics":["Case Report"],"weight":1,"_version_":1666138493458317315,"score":72.204384},{"pmid":32354773,"title":"Diagnostic and therapeutic challenges for patients with ANCA-associated vasculitides at the time of COVID-19. Response to: 'Rituximab for granulomatosis with polyangiitis in the pandemic of COVID-19: lessons from a case with severe pneumonia' by Guilpain et al.","text":["Diagnostic and therapeutic challenges for patients with ANCA-associated vasculitides at the time of COVID-19. Response to: 'Rituximab for granulomatosis with polyangiitis in the pandemic of COVID-19: lessons from a case with severe pneumonia' by Guilpain et al.","Ann Rheum Dis","Monti, Sara","Montecucco, Carlomaurizio","32354773"],"journal":"Ann Rheum Dis","authors":["Monti, Sara","Montecucco, Carlomaurizio"],"date":"2020-05-02T11:00:00Z","year":2020,"_id":"32354773","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1136/annrheumdis-2020-217555","keywords":["autoimmunity","rituximab","systemic vasculitis"],"e_drugs":["Rituximab"],"weight":0,"_version_":1666138495168544770,"score":68.618614}]}